Hyperimmune Globulins for the Management of Infectious Diseases

Viruses. 2023 Jul 13;15(7):1543. doi: 10.3390/v15071543.

Abstract

This review is focused on the use of hyperimmune globulin therapy to treat some infectious diseases of viral or bacterial origin. Despite the introduction of antibiotics and vaccines, plasma immunoglobulin therapy from whole blood donation can still play a key role. These treatments provide passive transfer of high-titer antibodies that either reduces the risk or the severity of the infection and offer immediate but short-term protection against specific diseases. Antibody preparations derived from immunized human donors are commonly used for the prophylaxis and treatment of rabies, hepatitis A and B viruses, varicella-zoster virus, and pneumonia caused by respiratory syncytial virus, Clostridium tetani, Clostridium botulinum. The use of hyperimmune globulin therapy is a promising challenge, especially for the treatment of emerging viral infections for which there are no specific therapies or licensed vaccines.

Keywords: convalescent plasma; human immunoglobulin; hyperimmune globulins; infectious diseases; therapy.

Publication types

  • Review

MeSH terms

  • Antibodies, Viral
  • Communicable Diseases* / therapy
  • Globulins*
  • Humans
  • Immunization, Passive
  • Immunoglobulins / therapeutic use
  • Vaccines*

Substances

  • Immunoglobulins
  • Globulins
  • Vaccines
  • Antibodies, Viral

Grants and funding

This research received no external funding.